For up-to-date news, find us on social media!
Follow us on twitter at @MU_CogNeuroLab
Find us on Facebook at MU Cognitive Neuroscience Laboratory
- Undergraduate student Christine Brunnert (mentored by Drs. Beversdorf and Ferguson) presented a poster titled, “The Relationship between Sensitivity to Environmental Stress and Gastrointestinal, Sensory, and Autism Spectrum Disorder Severity” at the Midwest Psychological Society conference in Chicago, IL.
- Undergraduate student Shannon Famuliner (mentored by Drs. Beversdorf and Ferguson) presented a poster titled, “Associations between dietary composition and gastrointestinal symptoms in autism spectrum disorder” during the University of Missouri Life Sciences Week. Her poster won an Honorable Mention among Social and Behavioral Sciences posters at Life Sciences Week.
- Dr. Beversdorf and the SFNC leadership organized the fourth annual Society for the Neuroscience of Creativity in Boston, MA, March 23, 2017
- Undergraduate student Molly McBride was awarded a College of Arts & Sciences Undergraduate Scholarship for 2018-2019.
- Undergraduate student Briann Sutton was chosen as the junior class recipient of the 2018 General Education Program/Hesburgh Awards for Student Academic Achievement from the he TIAA-CREF Hesburgh Endowment Fund, an academic achievement scholarship to one student from each of the four undergraduate classes.
- Dr. David Beversdorf received the Director of Graduate Studies Outstanding Contribution Award for 2018 from the Office of Graduate Studies for his role as Director of Graduate Studies for the Interdisciplinary Neuroscience Program.
- Dr. Rachel Zamzow published her paper on the ASD characteristics in a population of poodles in Journal of Comparative Psychology.
- Characterizing autism-relevant social behavior in poodles via owner report
- Dr. Beversdorf and the SFNC leadership organized the third annual Society for the Neuroscience of Creativity in San Francisco, CA, March 24, 2017
- Links to talks available on SFNC Facebook page
- Dr. Brad Ferguson has successfully defended his dissertation and earned a Ph.D.! He will be staying on to do his postdoctoral training with Dr. David Beversdorf.
- Dr. David Beversdorf published a position paper on the necessary direction for precision medicine in ASD with the 20+ authors of the Missouri Autism Summit.
- Phenotyping, etiological factors, and biomarkers: toward precision medicine in autism spectrum disorder
- Dr. John Hegarty published his paper on the effects of propranolol on resting state functional connectivity with fMRI in ASD.
- Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder
- Dr. Rachel Zamzow published on the effects of single-dose psychopharm challenge of propranolol and the role of psychophysiological markers on verbal problem solving in ASD
- Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers
- Dr. Beversdorf and the SFNC leadership organized the second annual Society for the Neuroscience of Creativity in San Diego, CA, November 11, 2016
- 2nd Meeting of the Society for the Neuroscience of Creativity, November 11, 2016, San Diego, CA
- Program Schedule NEW! Watch the SFNC2016 talks!
- April 2016: Dr. Rachel Zamzow successfully defended her dissertation and earned a Ph.D.! Congratulations to Rachel on her accomplishment!
- April, 2016: Dr. Brad Ferguson published 2 first-author papers: one on the relationship between psychophysiological markers of stress and gastrointestinal symptoms in ASD in Autism Research and another paper Brain, Behavior, and Immunity on the relationship between GI symptoms and endocrine and immune markers of stress in ASD.
- Psychophysiological associations with gastrointestinal symptomatology in autism spectrum disorder
- Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder
- “Trial of propranolol in children and youth with ASD and predictors of response”
- Funded by the Department of Defense Department of Defense office of the Congressionally Directed Medical Research Programs (CDMRP)-
- 2015 Autism Research Program
- Principal Investigator: David Beversdorf, M.D.
- This is a 4 year grant to examine the effect of propranolol in ASD while examining the roles of psychophysiological and neuroimaging biomarkers.
- Dr. Rachel Zamzow published on the effects of single-dose psychopharm challenge of propranolol on social interaction in ASD in Psychopharmacology
- Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single dose psychopharmacological challenge study
- Dr. Patrick Hecht published on the role of maternal genetic stress susceptibility in mediating the association between prenatal stress in ASD in two independent samples in Autism Research.
- Maternal serotonin transporter genotype affects risk of ASD with exposure to prenatal stress
- Dr. John Hegarty successfully defended his dissertation and earned a Ph.D.! John will be going to Stanford University to start a post-doctoral position under the guidance of Dr. Antonio Hardan.
- Dr. Patrick Hecht has successfully defended his dissertation and earned a Ph.D.! Congratulations to Patrick on his accomplishment.
- Rachel Zamzow recently published on the effects of propranolol on eye tracking in ASD,
- Effect of propranolol on facial scanning in autism spectrum disorder: A preliminary investigation
- Patrick Hecht published on pharmacological modulation of cognitive flexibility,
- Beta-adrenergic antagonist effects on a novel cognitive flexibility task in rodents
- Dr. Beversdorf organized the first annual Society for the Neuroscience of Creativity in Chicago, IL, October 16, 2015
- 1st Meeting of the Society for the Neuroscience of Creativity, October 16, 2015, Chicago, IL. Program Schedule